Your browser is no longer supported. Please, upgrade your browser.
Settings
MTACU [NASD]
MedTech Acquisition Corporation
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week1.49%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float23.62M Perf Month0.79%
Income- PEG- EPS next Q- Inst Own40.85% Short Float0.21% Perf Quarter0.49%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio2.52 Perf Half Y-0.39%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range9.86 - 11.85 Perf YTD-2.38%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-13.50% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low3.96% ATR0.10
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)58.67 Volatility0.45% 0.81%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.06 Prev Close10.20
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume19.92K Price10.25
Recom- SMA201.70% SMA501.80% SMA200-0.44% Volume21,198 Change0.49%
Sep-09-21 06:00AM  
Sep-03-21 09:25AM  
Aug-19-21 12:32PM  
Aug-13-21 05:49PM  
08:07AM  
Jun-02-21 04:05PM  
May-19-21 01:02PM  
Feb-05-21 04:05PM  
Dec-22-20 05:12PM  
MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.